Many COVID-19 patients who took the antiviral treatment Paxlovid said
their symptoms appear to rebound after taking the five-day course of
medication, my colleague Kay
Lazar reported. Others went so far to say that after feeling
better and testing negative, they then tested positive again a few days
later.
The issue has captured the attention of at least two teams of Boston-area scientists,
who are trying to understand what might be fueling the problem.
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, May 3, 2022
The puzzling phenomenon of Paxlovid
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment